Elon Musk’s Neuralink said on Monday that it had raised US$650 million (A$1 billion) in its latest funding round as its brain implant device enters clinical trials. “This funding helps us bring our technology to more people — restoring independence for those with unmet medical needs and pushing the boundaries of what’s possible with brain…

The post Neuralink raises $1bn in latest funding as clinical trials begin appeared first on InnovationAus.com.

This post was originally published on InnovationAus.com.